Abstract
Treatment of multidrug-resistant Gram-negative bacterial pathogens represents a critical clinical need. Here, we report a novel γ-lactam pyrazolidinone that targets penicillin-binding proteins (PBPs) and incorporates a siderophore moiety to facilitate uptake into the periplasm. The MIC values of γ-lactam YU253434, 1, are reported along with the finding that 1 is resistant to hydrolysis by all four classes of β-lactamases. The druglike characteristics and mouse PK data are described along with the X-ray crystal structure of 1 binding to its target PBP3.
Original language | English (US) |
---|---|
Pages (from-to) | 5990-6002 |
Number of pages | 13 |
Journal | Journal of medicinal chemistry |
Volume | 63 |
Issue number | 11 |
DOIs | |
State | Published - Jun 11 2020 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery